Critically, given that gut microbiota dysbiosis drives cholestatic pathogenesis via impaired FXR-FGF15 signaling, we hypothesize that YCHD alleviates cholestasis by remodeling microbial communities to activate the FXR-FGF15 axis. The gene discussed is NR1H4; the disease is cholestasis.